Prinoxodan

Prinoxodan (RGW2938) is a phosphodiesterase inhibitor.

Product Specifications

CAS Number

[111786-07-3]

Product Name Alternative

RGW2938

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Phosphodiesterase (PDE)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/RGW2938.html

Purity

99.83

Solubility

Ethanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C1NC2=C(C=C(C3=NNC(CC3)=O)C=C2)CN1C

Molecular Formula

C13H14N4O2

Molecular Weight

258.28

Precautions

H302, H315, H319, H335

References & Citations

[1]Artigou JY, et al. [Evaluation of a new cardiotonic agent on human isolated atrium]. Ann Cardiol Angeiol (Paris) . 1993 Feb;42 (2) :79-82.|[2]Barrett JA, et al. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity. J Cardiovasc Pharmacol. 1990 Oct;16 (4) :537-45.